Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease

Clinical and Experimental Immunology

Volumn 148, Issue 2, 2007, Pages 230-240

  Westerlund, A ^a   Ankelo, M ^a   Simell, S ^b   Ilonen, J ^b,c   Knip, M ^d,e   Simell, O ^b   Hinkkanen, A E ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autoantibody; Avidity; Coeliac disease; Tissue transglutaminase; Transient IgA TGA

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RECOMBINANT PROTEIN; UREA;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELIAC DISEASE; CHEMICAL MODIFICATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SCREENING TEST; SEROCONVERSION; STATISTICAL SIGNIFICANCE;

AGING; ANTIBODY AFFINITY; AUTOANTIBODIES; BINDING, COMPETITIVE; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN A; INFANT; MALE; REPRODUCIBILITY OF RESULTS; TRANSGLUTAMINASES;

EID: 34247121902     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03336.x     Document Type: Article

References (33)

1. Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int J Biochem Cell Biol 2004; 36:17-24.
2. Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical formof celiac disease. Which is now themain formof celiac disease in clinical practice? Minerva Gastroenterol Dietol 2002; 48:121-30.
3. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346:180-8.
4. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999; 353:813-4.
5. Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr 2000; 136:86-90.
6. Mäki M, Mustalahti K, Kokkonen J et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348:2517-24.
7. Bao F, Yu L, Babu S et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999; 13:143-8.
8. Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol 2001; 8:678-85.
9. Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002; 37:51-5.
10. Högberg L, Fälth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 2003; 38:61-5.
11. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2:647-55.
12. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797-801.
13. Bürgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol 2002; 37:685-91.
14. Osman AA, Richter T, Stern M et al. Production of recombinant human tissue transglutaminase using the baculovirus expression system, and its application for serological diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 2002; 14:1217-23.
15. Fernandez E, Riestra S, Rodrigo L et al. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol 2005; 11:3762-6.
16. Zintzaras E, Germenis AE. Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis. Clin Vaccine Immunol 2006; 13:187-92.
17. Troncone R, Maurano F, Rossi M et al. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr 1999; 134:166-71.
18. Kumar V, Jarzabek-Chorzelska M, Sulej J, Karnewska K, Farrell T, Jablonska S. Celiac disease and immunoglobulin A deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol 2002; 9:1295-300.
19. Korponay-Szabó IR, Dahlbom I, Laurila K et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 2003; 52:1567-71.
20. Dahlbom I, Olsson M, Forooz NK, Sjoholm AG, Truedsson L, Hansson T. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol 2005; 12:254-8.
21. Chartrand LJ, Seidman EG. Celiac disease is a lifelong disorder. Clin Invest Med 1996; 19:357-61.
22. Schmitz J. Is celiac disease a lifelong disorder? Clin Invest Med 1996; 19:352-6.
23. Liu E, Bao F, Barriga K et al. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol 2003; 1:356-62.
24. Simell S, Kupila A, Hoppu S et al. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 2005; 40:1182-91.
25. Villalta D, Romelli PB, Savina C et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 2003; 12:31-6.
26. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114:589-97.
27. Schlosser M, Koczwara K, Kenk H et al. In insulin-autoantibody- positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 2005; 48:1830-2.
28. Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes. J Autoimmun 2005; 24:153-67.
29. Saalman R, Dahlgren UI, Fallstrom SP, Hanson LA, Ahlstedt S, Wold AE. Avidity progression of dietary antibodies in healthy and coeliac children. Clin Exp Immunol 2003; 134:328-34.
30. Vainio E, Kosnai I, Hallstrom O, Karpati S, Maki M, Reunala T. Antigliadin and antireticulin antibodies in children with dermatitis herpetiformis. J Pediatr Gastroenterol Nutr 1986; 5:735-9.
31. Ankelo M, Westerlund-Karlsson A, Ilonen J et al. Time-resolved fluorometric assay for detection of autoantibodies to glutamic acid decarboxylase (GAD65). Clin Chem 2003; 49:908-15.
32. Westerlund-Karlsson A, Suonpää K, Ankelo M, Ilonen J, Knip M, Hinkkanen AE. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay. Clin Chem 2003; 49:916-23.
33. Kupila A, Muona P, Simell T et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Diabetologia 2001; 44:290-7.